France· FR:64441114
GIAPREZA 2,5 mg/ml, solution à diluer pour perfusion
A medicinal product containing acétate d'angiotensine ii, registered in France by PAION PHARMA (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- ACÉTATE D'ANGIOTENSINE II
- Manufacturer
- PAION PHARMA (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip13340095509533010 flacons en verre de 1 mL
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Acétate d'angiotensine ii in 7 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsGiapreza 2,5 mg/ml concentraat voor oplossing voor infusiePaion Pharma GmbH
- United StatesANGIOTENSIN IIGland Pharma Limited
- United KingdomGiapreza 2.5mg/1ml concentrate for solution for infusion vialsPAION Pharma GmbH
- IcelandGiaprezaPAION Pharma GmbH
- SpainGIAPREZA 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSIONPaion Pharma Gmbh
- NorwayGiaprezaPAION Pharma GmbH
- SwedenGIAPREZA 2,5 mg/ml Koncentrat till infusionsvätska, lösningPAION Pharma GmbH
Authorised across Europe · EMA
The same active substance is authorised in 3 EEA countries. Names it is sold under:
- Iceland · Giapreza
- Liechtenstein · Giapreza
- Norway · Giapreza
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/3fc10a1f-3c24-44c5-a351-e3651b677656 GET /v1/drugs/3fc10a1f-3c24-44c5-a351-e3651b677656?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "64441114",
"date_amm": "2019-08-23",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/19/1384",
"substance": "ACÉTATE D'ANGIOTENSINE II",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution à diluer pour perfusion",
"voies_administration": "intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Oui"
}See everything about acétate d'angiotensine ii.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.